Cat. No. 5602
Chemical Name: 3-[(2,5-Dimethylphenyl)amino]-1-phe
Biological ActivityCD40-TRAF6 interaction inhibitor. Suppresses CD40-induced IL-1β and IL-6 expression in macrophages in vitro. Improves insulin sensitivity, reduces adipose tissue inflammation, and ameliorates hepatosteatosis in diet-induced obese mice.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Chatzigeorgiou et al (2014) Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Proc.Natl.Acad.Sci.U.S.A. 111 2686. PMID: 24492375.
If you know of a relevant reference for 6877002 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses 6877002 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: 6877002, supplier, cd40, traf6, tnfalpha, tnfa, tnfα, superfamily, cytokines, receptors, inhibitors, inhibits, inflammation, obesity, diabetes, insulin, Tocris Bioscience, Cytokine Receptor products
Find multiple products by catalog number
New Products in this Area
DR5 (TRAIL receptor) agonist; induces apoptosisBOP
Dual α9β/1α4β1 integrin inhibitor; preferentially mobilizes HSCs
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.